{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:20:46Z","timestamp":1793931646610,"version":"4.8.0"},"reference-count":37,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Dexmedetomidine (Dex) is widely used in perioperative anesthesia, and\nrecent studies have reported that it protects organs from ischemia\/reperfusion (I\/R) injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study was performed to investigate the role of Dex in alleviating cerebral I\/R injury and its regulatory effects on metastasis-associated lung adenocarcinoma transcript 1\n(MALAT1)\/microRNA-140-5p (miR-140-5p)\/nuclear factor erythroid-derived 2-like 2 (Nrf2)\naxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In vivo rat middle cerebral artery occlusion (MCAO) model and in vitro oxygen-glucose\ndeprivation\/re-oxygenation (OGD\/R)-induced neuronal injury model were constructed. Dex was\ninjected into the animals or used to culture HT22 cells to observe the pharmacological effects. The\nneurological defect, brain water content, infarct volume of the rats, and neuron viability were evaluated. The levels of reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT) were detected. Besides, the regulatory effects of Dex on\nMALAT1, miR-140-5p, and Nrf2 expression levels and regulatory relationships among them were\nevaluated by quantitative real-time polymerase chain reaction (qRT-PCR), Western blot, and dual-luciferase reporter assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Dex significantly alleviated the neurological injury of rats with MCAO and promoted the\nviability of neurons. Dex treatment suppressed miR-140-5p expression, but elevated MALAT1\nand Nrf2 expressions. MALAT1 knockdown down-regulated Nrf2 expression and promoted oxidative stress in neurons. Additionally, miR-140-5p directly targeted Nrf2, and it also functioned as a\ndownstream target miRNA of MALAT1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Dex, via regulating MALAT1\/miR-140-5p\/Nrf2 axis, plays a neuroprotective role\nagainst I\/R-induced brain injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298665254683231122065717","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T02:05:30Z","timestamp":1702346730000},"page":"116-127","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Dexmedetomidine Alleviates Brain Ischemia\/Reperfusion Injury by\nRegulating Metastasis-associated Lung Adenocarcinoma Transcript\n1\/MicroRNA-140-5p\/ Nuclear Factor Erythroid-derived 2-like 2 Axis"],"prefix":"10.2174","volume":"31","author":[{"given":"Zhigang","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, TaiKang Tongji (Wuhan) Hospital, Wuhan430000, Hubei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Hanyang Hospital, Wuhan 430000, Hubei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e43752","DOI":"10.7759\/cureus.43752","volume":"15","author":"Alkutbi A.","year":"2023","unstructured":"Alkutbi A.; Binmahfooz S.; AlSaidlani R.H.; Albeirouti R.B.; Kamal O.; Alalawi H.; Aljehani M.N.; Khared M.; Ayoub O.A.; Clinical characteristics of ischemic stroke patients <50 years old at a university hospital: A retrospective descriptive study. Cureus  2023,15(8),e43752","journal-title":"Cureus"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/jamaneurol.2016.5823","volume":"74","author":"Gerschenfeld G.","year":"2017","unstructured":"Gerschenfeld G.; Muresan I.P.; Blanc R.; Obadia M.; Abrivard M.; Piotin M.; Alamowitch S.; Two paradigms for endovascular thrombectomy after intravenous thrombolysis for acute ischemic stroke. JAMA Neurol  2017,74(5),549-556","journal-title":"JAMA Neurol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12967-018-1753-7","volume":"17","author":"Wetzel M.D.","year":"2019","unstructured":"Wetzel M.D.; Wenke J.C.; Mechanisms by which hydrogen sulfide attenuates muscle function following ischemia\u2013reperfusion injury: effects on Akt signaling, mitochondrial function, and apoptosis. J Transl Med  2019,17(1),33","journal-title":"J Transl Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s12975-020-00789-x","volume":"11","author":"Wang Z.","year":"2020","unstructured":"Wang Z.; Higashikawa K.; Yasui H.; Kuge Y.; Ohno Y.; Kihara A.; Midori Y.A.; Houkin K.; Kawabori M.; FTY720 protects against ischemia\u2013reperfusion injury by preventing the redistribution of tight junction proteins and decreases inflammation in the subacute phase in an experimental stroke model. Transl Stroke Res  2020,11(5),1103-1116","journal-title":"Transl Stroke Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fphar.2020.00424","volume":"11","author":"Wang J.","year":"2020","unstructured":"Wang J.; Mao J.; Wang R.; Li S.; Wu B.; Yuan Y.; Kaempferol protects against cerebral ischemia reperfusion injury through intervening oxidative and inflammatory stress induced apoptosis. Front Pharmacol  2020,11,424","journal-title":"Front Pharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s13063-023-07632-2","volume":"24","author":"Li M.","year":"2023","unstructured":"Li M.; Liu M.; Cui Q.; Zeng M.; Li S.; Zhang L.; Peng Y.; Effect of dexmedetomidine on postoperative delirium in patients undergoing awake craniotomies: Study protocol of a randomized controlled trial. Trials  2023,24(1),607","journal-title":"Trials"},{"key":"ref=7","first-page":"164","volume":"29","author":"Lyu J.","year":"2023","unstructured":"Lyu J.; Zhou Y.; Zhang M.; Tang L.; Bao X.; Sun Z.; Huang L.; Zhao L.; Neuroprotective effect of dexmedetomidine on cerebral ischemia-reperfusion injury in rats. Altern Ther Health Med  2023,29(6),164-169","journal-title":"Altern Ther Health Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10735-023-10120-1","volume":"54","author":"Li J.","year":"2023","unstructured":"Li J.; Wang K.; Liu M.; He J.; Zhang H.; Liu H.; Dexmedetomidine alleviates cerebral ischemia-reperfusion injury via inhibiting autophagy through PI3K\/Akt\/mTOR pathway. J Mol Histol  2023,54(3),173-181","journal-title":"J Mol Histol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1213\/ANE.0000000000006487","volume":"137","author":"Chen Z.R.","year":"2023","unstructured":"Chen Z.R.; Hong Y.; Wen S.H.; Zhan Y.Q.; Huang W.Q.; Dexmedetomidine pretreatment protects against myocardial ischemia\/reperfusion injury by activating STAT3 signaling. Anesth Analg  2023,137(2),426-439","journal-title":"Anesth Analg"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"37196","DOI":"10.1038\/srep37196","volume":"6","author":"Akp\u0131nar H.","year":"2016","unstructured":"Akp\u0131nar H.; Naz\u0131ro\u011flu M.; \u00d6vey \u0130.S.; \u00c7i\u011f B.; Akp\u0131nar O.; The neuroprotective action of dexmedetomidine on apoptosis, calcium entry and oxidative stress in cerebral ischemia-induced rats: Contribution of TRPM2 and TRPV1 channels. Sci Rep  2016,6(1),37196","journal-title":"Sci Rep"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.biopha.2017.06.051","volume":"93","author":"Wang S.L.","year":"2017","unstructured":"Wang S.L.; Duan L.; Xia B.; Liu Z.; Wang Y.; Wang G.M.; Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4\/NF-\u03baB pathways model of cerebral ischemia reperfusion. Biomed Pharmacother  2017,93,1337-1342","journal-title":"Biomed Pharmacother"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1007\/s11064-023-03991-z","volume":"48","author":"Huang S.","year":"2023","unstructured":"Huang S.; Hou D.; Zhang L.; Pei C.; Liang J.; Li J.; Yang G.; Yu D.; LncRNA MALAT1 promoted neuronal necroptosis in cerebral ischemia-reperfusion mice by stabilizing HSP90. Neurochem Res  2023,48(11),3457-3471","journal-title":"Neurochem Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12929-020-00635-0","volume":"27","author":"Wang H.","year":"2020","unstructured":"Wang H.; Zheng X.; Jin J.; Zheng L.; Guan T.; Huo Y.; Xie S.; Wu Y.; Chen W.; LncRNA MALAT1 silencing protects against cerebral ischemia-reperfusion injury through miR-145 to regulate AQP4. J Biomed Sci  2020,27(1),40","journal-title":"J Biomed Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1523\/JNEUROSCI.3389-16.2017","volume":"37","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; Tang X.; Liu K.; Hamblin M.H.; Yin K.J.; Long Noncoding RNA Malat1 regulates cerebrovascular pathologies in ischemic stroke. J Neurosci  2017,37(7),1797-1806","journal-title":"J Neurosci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.3892\/etm.2019.7220","volume":"17","author":"Zhang W.","year":"2019","unstructured":"Zhang W.; Meng A.; MicroRNA\u2011124 expression in the brains of rats during early cerebral ischemia and reperfusion injury is associated with cell apoptosis involving STAT3. Exp Ther Med  2019,17(4),2870-2876","journal-title":"Exp Ther Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"12899","DOI":"10.3390\/ijms241612899","volume":"24","author":"Tregub P.P.","year":"2023","unstructured":"Tregub P.P.; Ibrahimli I.; Averchuk A.S.; Salmina A.B.; Litvitskiy P.F.; Manasova Z.S.; Popova I.A.; The Role of microRNAs in epigenetic regulation of signaling pathways in neurological pathologies. Int J Mol Sci  2023,24(16),12899","journal-title":"Int J Mol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12031-019-01384-y","volume":"69","author":"Teng L.","year":"2019","unstructured":"Teng L.; Meng R.; Long Non-Coding RNA MALAT1 promotes acute cerebral infarction through mirnas-mediated hs-crp regulation. J Mol Neurosci  2019,69(3),494-504","journal-title":"J Mol Neurosci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.31083\/j.jin2204081","volume":"22","author":"Abdul-Muneer P.M.","year":"2023","unstructured":"Abdul-Muneer P.M.; Nrf2 as a potential therapeutic target for traumatic brain injury. J Integr Neurosci  2023,22(4),81","journal-title":"J Integr Neurosci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00011-017-1095-6","volume":"67","author":"Xu X.","year":"2018","unstructured":"Xu X.; Zhang L.; Ye X.; Hao Q.; Zhang T.; Cui G.; Yu M.; Nrf2\/ARE pathway inhibits ROS-induced NLRP3 inflammasome activation in BV2 cells after cerebral ischemia reperfusion. Inflamm Res  2018,67(1),57-65","journal-title":"Inflamm Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1089\/ars.2016.6885","volume":"27","author":"Wu G.","year":"2017","unstructured":"Wu G.; Zhu L.; Yuan X.; Chen H.; Xiong R.; Zhang S.; Cheng H.; Shen Y.; An H.; Li T.; Li H.; Zhang W.; Britanin ameliorates cerebral ischemia\u2013reperfusion injury by inducing the nrf2 protective pathway. Antioxid Redox Signal  2017,27(11),754-768","journal-title":"Antioxid Redox Signal"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells11010012","volume":"11","author":"Mahajan M.","year":"2021","unstructured":"Mahajan M.; Sitasawad S.; miR-140-5p attenuates hypoxia-induced breast cancer progression by targeting Nrf2\/HO-1 Axis in a keap1-independent mechanism. Cells  2021,11(1),12","journal-title":"Cells"},{"key":"ref=22","first-page":"839","volume":"43","author":"Liu Q.Q.","year":"2019","unstructured":"Liu Q.Q.; Ren K.; Liu S.H.; Li W.M.; Huang C.J.; Yang X.H.; MicroRNA-140-5p aggravates hypertension and oxidative stress of atherosclerosis via targeting Nrf2 and Sirt2. Int J Mol Med  2019,43(2),839-849","journal-title":"Int J Mol Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21315\/mjms2017.24.5.11","volume":"24","author":"Wan Mohammad W.M.Z.","year":"2017","unstructured":"Wan Mohammad W.M.Z.; Zahiruddin W.M.; Sample size calculation in animal studies using resource equation approach. Malays J Med Sci  2017,24(5),101-105","journal-title":"Malays J Med Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/01.STR.32.4.1005","volume":"32","author":"Chen J.","year":"2001","unstructured":"Chen J.; Li Y.; Wang L.; Zhang Z.; Lu D.; Lu M.; Chopp M.; Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke  2001,32(4),1005-1011","journal-title":"Stroke"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1379162","volume":"2016","author":"Hu H.","year":"2016","unstructured":"Hu H.; Sun X.; Tian F.; Zhang H.; Liu Q.; Tan W.; Neuroprotective effects of isosteviol sodium injection on acute focal cerebral ischemia in rats. Oxid Med Cell Longev  2016,2016,1-10","journal-title":"Oxid Med Cell Longev"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"Reagan-Shaw S.","year":"2008","unstructured":"Reagan-Shaw S.; Nihal M.; Ahmad N.; Dose translation from animal to human studies revisited. FASEB J  2008,22(3),659-661","journal-title":"FASEB J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"116921","DOI":"10.1016\/j.lfs.2019.116921","volume":"236","author":"Li P.","year":"2019","unstructured":"Li P.; Zhang Y.; Liu H.; The role of Wnt\/\u03b2-catenin pathway in the protection process by dexmedetomidine against cerebral ischemia\/reperfusion injury in rats. Life Sci  2019,236,116921","journal-title":"Life Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"114671","DOI":"10.1016\/j.biopha.2023.114671","volume":"162","author":"Huang J.","year":"2023","unstructured":"Huang J.; Chen L.; Yao Z.; Sun X.; Tong X.; Dong S.; The role of mitochondrial dynamics in cerebral ischemia-reperfusion injury. Biomed Pharmacother  2023,162,114671","journal-title":"Biomed Pharmacother"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3390\/antiox10091384","volume":"10","author":"Vongsfak J.","year":"2021","unstructured":"Vongsfak J.; Pratchayasakul W.; Apaijai N.; Vaniyapong T.; Chattipakorn N.; Chattipakorn S.C.; The alterations in mitochondrial dynamics following cerebral ischemia\/reperfusion injury. Antioxidants  2021,10(9),1384","journal-title":"Antioxidants"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.apsb.2014.11.002","volume":"5","author":"Sun K.","year":"2015","unstructured":"Sun K.; Fan J.; Han J.; Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia\/reperfusion-induced cerebral microcirculatory disturbances and neuron damage. Acta Pharm Sin B  2015,5(1),8-24","journal-title":"Acta Pharm Sin B"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.ymthe.2023.04.012","volume":"31","author":"Zong Y.","year":"2023","unstructured":"Zong Y.; Wang X.; Cui B.; Xiong X.; Wu A.; Lin C.; Zhang Y.; Decoding the regulatory roles of non-coding RNAs in cellular metabolism and disease. Mol Ther  2023,31(6),1562-1576","journal-title":"Mol Ther"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1158\/1535-7163.MCT-19-0203","volume":"19","author":"Fan L.","year":"2020","unstructured":"Fan L.; Huang X.; Chen J.; Zhang K.; Gu Y.; Sun J.; Cui S.; Long noncoding RNA MALAT1 contributes to sorafenib resistance by targeting miR-140-5p\/Aurora-A signaling in hepatocellular carcinoma. Mol Cancer Ther  2020,19(5),1197-1209","journal-title":"Mol Cancer Ther"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10571-018-00646-4","volume":"39","author":"Ruan W.","year":"2019","unstructured":"Ruan W.; Li J.; Xu Y.; Wang Y.; Zhao F.; Yang X.; Jiang H.; Zhang L.; Saavedra J.M.; Shi L.; Pang T.; MALAT1 Up-Regulator polydatin protects brain microvascular integrity and ameliorates stroke through C\/EBP\u03b2\/MALAT1\/ CREB\/PGC-1\u03b1\/PPAR\u03b3 Pathway. Cell Mol Neurobiol  2019,39(2),265-286","journal-title":"Cell Mol Neurobiol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"8346","DOI":"10.1038\/s41598-018-26421-5","volume":"8","author":"Wang L.Q.","year":"2018","unstructured":"Wang L.Q.; Zhou H.J.; LncRNA MALAT1 promotes high glucose-induced inflammatory response of microglial cells via provoking MyD88\/IRAK1\/TRAF6 signaling. Sci Rep  2018,8(1),8346","journal-title":"Sci Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41401-019-0284-y","volume":"41","author":"Cao D.","year":"2020","unstructured":"Cao D.; Liu M.; Duan R.; Tao Y.; Zhou J.; Fang W.; Zhu J.; Niu L.; Sun J.; The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation. Acta Pharmacol Sin  2020,41(1),22-33","journal-title":"Acta Pharmacol Sin"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"55051","DOI":"10.18632\/oncotarget.19017","volume":"8","author":"Chen J.Y.","year":"2017","unstructured":"Chen J.Y.; Zhu G.Y.; Su X.H.; Wang R.; Liu J.; Liao K.; Ren R.; Li T.; Liu L.; 7-deacetylgedunin suppresses inflammatory responses through activation of Keap1\/Nrf2\/HO-1 signaling. Oncotarget  2017,8(33),55051-55063","journal-title":"Oncotarget"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.redox.2017.12.013","volume":"15","author":"Zhao L.","year":"2018","unstructured":"Zhao L.; Qi Y.; Xu L.; Tao X.; Han X.; Yin L.; Peng J.; MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biol  2018,15,284-296","journal-title":"Redox Biol"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665254683231122065717","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/224330\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665254683231122065717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T08:27:36Z","timestamp":1713947256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/224330\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665254683231122065717","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-05-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}